Maciag, Anna E.; CHAKRAPANI, HARINATH et al.
(American Chemical Society, 2011-10)
Improved therapies are needed for nonsmall cell lung cancer. Diazeniumdiolate-based nitric oxide (NO)-releasing prodrugs are a growing class of promising NO-based therapeutics. Recently, we have shown that O2-(2,4-dinitrophenyl) ...